UTHR logo

UTHR Selling, General & Administrative Expenses

Annual SG&A:

$638.60M+$161.50M(+33.85%)
December 31, 2024

Summary

  • As of today, UTHR annual SG&A is $638.60 million, with the most recent change of +$161.50 million (+33.85%) on December 31, 2024.
  • During the last 3 years, UTHR annual SG&A has risen by +$171.60 million (+36.75%).
  • UTHR annual SG&A is now at all-time high.

Performance

UTHR SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

Quarterly SG&A:

$152.00M-$10.10M(-6.23%)
September 30, 2025

Summary

  • As of today, UTHR quarterly SG&A is $152.00 million, with the most recent change of -$10.10 million (-6.23%) on September 30, 2025.
  • Over the past year, UTHR quarterly SG&A has increased by +$30.90 million (+25.52%).
  • UTHR quarterly SG&A is now -28.08% below its all-time high of $211.34 million, reached on March 31, 2015.

Performance

UTHR Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

TTM SG&A:

$30.81B+$1.27B(+4.30%)
September 30, 2025

Summary

  • As of today, UTHR TTM SG&A is $30.81 billion, with the most recent change of +$1.27 billion (+4.30%) on September 30, 2025.
  • Over the past year, UTHR TTM SG&A has increased by +$30.31 billion (+5965.57%).
  • UTHR TTM SG&A is now at all-time high.

Performance

UTHR TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

UTHR Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+33.9%+25.5%+5965.6%
3Y3 Years+36.8%+47.7%+7922.2%
5Y5 Years+90.0%+102.1%+9654.1%

UTHR Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+36.8%-10.6%+51.1%at high+67.0%
5Y5-Yearat high+90.0%-10.6%+102.1%at high+118.6%
All-TimeAll-Timeat high>+9999.0%-28.1%+979.8%at high+4053.0%

UTHR Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$152.00M(-6.2%)
$627.50M(+5.2%)
Jun 2025
-
$162.10M(-4.7%)
$596.60M(+4.1%)
Mar 2025
-
$170.10M(+18.7%)
$572.90M(+8.3%)
Dec 2024
$638.60M(+33.9%)
$143.30M(+18.3%)
$529.10M(+4.2%)
Sep 2024
-
$121.10M(-12.5%)
$508.00M(+2.0%)
Jun 2024
-
$138.40M(+9.6%)
$498.00M(+3.4%)
Mar 2024
-
$126.30M(+3.4%)
$481.70M(+5.6%)
Dec 2023
$477.10M(-1.0%)
$122.20M(+10.0%)
$456.00M(+2.2%)
Sep 2023
-
$111.10M(-9.0%)
$446.10M(+1.9%)
Jun 2023
-
$122.10M(+21.4%)
$437.90M(+7.1%)
Mar 2023
-
$100.60M(-10.4%)
$408.80M(+1.2%)
Dec 2022
$482.10M(+3.2%)
$112.30M(+9.1%)
$404.00M(+5.2%)
Sep 2022
-
$102.90M(+10.6%)
$384.10M(+3.2%)
Jun 2022
-
$93.00M(-2.9%)
$372.30M(+0.8%)
Mar 2022
-
$95.80M(+3.7%)
$369.20M(+2.9%)
Dec 2021
$467.00M(+10.2%)
$92.40M(+1.4%)
$358.70M(+1.8%)
Sep 2021
-
$91.10M(+1.3%)
$352.30M(+4.7%)
Jun 2021
-
$89.90M(+5.4%)
$336.40M(+7.1%)
Mar 2021
-
$85.30M(-0.8%)
$314.00M(+5.8%)
Dec 2020
$423.90M(+26.1%)
$86.00M(+14.4%)
$296.70M(-6.1%)
Sep 2020
-
$75.20M(+11.4%)
$315.90M(-7.1%)
Jun 2020
-
$67.50M(-0.7%)
$340.10M(+8.9%)
Mar 2020
-
$68.00M(-35.4%)
$312.20M(-7.1%)
Dec 2019
$336.20M(+26.5%)
$105.20M(+5.8%)
$336.20M(+8.4%)
Sep 2019
-
$99.40M(+151.0%)
$310.20M(-3.3%)
Jun 2019
-
$39.60M(-57.0%)
$320.90M(-11.9%)
Mar 2019
-
$92.00M(+16.2%)
$364.40M(+37.1%)
Dec 2018
$265.80M(-19.5%)
$79.20M(-28.1%)
$265.80M(-23.1%)
Sep 2018
-
$110.10M(+32.5%)
$345.70M(+22.2%)
Jun 2018
-
$83.10M(+1359.1%)
$282.80M(+5.9%)
Mar 2018
-
-$6.60M(-104.1%)
$267.10M(-19.1%)
Dec 2017
$330.10M(+4.2%)
$159.10M(+237.1%)
$330.10M(+6.3%)
Sep 2017
-
$47.20M(-30.0%)
$310.50M(-14.6%)
Jun 2017
-
$67.40M(+19.5%)
$363.40M(-1.3%)
Mar 2017
-
$56.40M(-59.6%)
$368.20M(+16.2%)
Dec 2016
$316.80M(-30.0%)
$139.50M(+39.4%)
$316.80M(-2.8%)
Sep 2016
-
$100.10M(+38.6%)
$325.86M(+56.3%)
Jun 2016
-
$72.20M(+1344.0%)
$208.49M(-15.3%)
Mar 2016
-
$5.00M(-96.6%)
$246.27M(-45.6%)
Dec 2015
$452.70M(+18.7%)
$148.56M(+959.9%)
$452.61M(+17.7%)
Sep 2015
-
-$17.28M(-115.7%)
$384.58M(-36.4%)
Jun 2015
-
$109.99M(-48.0%)
$604.37M(+7.5%)
Mar 2015
-
$211.34M(+162.4%)
$562.41M(+47.5%)
Dec 2014
$381.30M(-3.2%)
$80.53M(-60.2%)
$381.29M(-16.7%)
Sep 2014
-
$202.51M(+197.7%)
$457.93M(+31.0%)
Jun 2014
-
$68.03M(+125.2%)
$349.54M(-0.9%)
Mar 2014
-
$30.21M(-80.8%)
$352.87M(-10.4%)
Dec 2013
$394.01M(+95.3%)
$157.18M(+67.0%)
$394.01M(+42.3%)
Sep 2013
-
$94.11M(+31.9%)
$276.90M(+10.1%)
Jun 2013
-
$71.36M(+0.0%)
$251.42M(+7.8%)
Mar 2013
-
$71.36M(+78.1%)
$233.31M(+15.6%)
Dec 2012
$201.75M
$40.07M(-41.6%)
$201.75M(-8.0%)
Sep 2012
-
$68.63M(+28.9%)
$219.38M(+31.0%)
Jun 2012
-
$53.26M(+33.9%)
$167.41M(+21.3%)
DateAnnualQuarterlyTTM
Mar 2012
-
$39.79M(-31.0%)
$138.01M(-12.4%)
Dec 2011
$156.48M(-17.0%)
$57.71M(+246.5%)
$157.45M(+32.1%)
Sep 2011
-
$16.66M(-30.2%)
$119.21M(-20.1%)
Jun 2011
-
$23.86M(-59.7%)
$149.25M(-4.6%)
Mar 2011
-
$59.23M(+204.3%)
$156.43M(+8.7%)
Dec 2010
$188.61M(+7.0%)
$19.47M(-58.3%)
$143.88M(-20.5%)
Sep 2010
-
$46.69M(+50.4%)
$180.99M(+3.1%)
Jun 2010
-
$31.04M(-33.5%)
$175.48M(-9.5%)
Mar 2010
-
$46.69M(-17.5%)
$193.81M(+9.9%)
Dec 2009
$176.34M(+87.0%)
$56.58M(+37.4%)
$176.34M(+24.5%)
Sep 2009
-
$41.17M(-16.6%)
$141.63M(+8.5%)
Jun 2009
-
$49.37M(+69.0%)
$130.47M(+25.2%)
Mar 2009
-
$29.22M(+33.6%)
$104.19M(+10.5%)
Dec 2008
$94.31M(-4.8%)
$21.86M(-27.2%)
$94.31M(-17.7%)
Sep 2008
-
$30.02M(+30.0%)
$114.60M(+12.1%)
Jun 2008
-
$23.09M(+19.5%)
$102.25M(+2.6%)
Mar 2008
-
$19.33M(-54.1%)
$99.63M(+4.4%)
Dec 2007
$99.03M(+83.3%)
$42.16M(+138.7%)
$95.46M(+31.7%)
Sep 2007
-
$17.66M(-13.7%)
$72.49M(+7.0%)
Jun 2007
-
$20.47M(+35.0%)
$67.72M(+14.6%)
Mar 2007
-
$15.16M(-21.0%)
$59.11M(+9.4%)
Dec 2006
$54.03M(+119.1%)
$19.19M(+48.8%)
$54.03M(+30.2%)
Sep 2006
-
$12.89M(+8.6%)
$41.51M(+21.2%)
Jun 2006
-
$11.87M(+17.8%)
$34.24M(+16.5%)
Mar 2006
-
$10.08M(+51.1%)
$29.39M(+19.2%)
Dec 2005
$24.66M(+14.5%)
$6.67M(+18.7%)
$24.66M(+4.8%)
Sep 2005
-
$5.62M(-20.0%)
$23.53M(+3.5%)
Jun 2005
-
$7.03M(+31.6%)
$22.73M(+7.9%)
Mar 2005
-
$5.34M(-3.7%)
$21.06M(-2.2%)
Dec 2004
$21.53M(-5.0%)
$5.55M(+15.2%)
$21.53M(-2.3%)
Sep 2004
-
$4.82M(-10.1%)
$22.04M(-3.5%)
Jun 2004
-
$5.36M(-7.8%)
$22.85M(-2.7%)
Mar 2004
-
$5.81M(-4.1%)
$23.49M(+3.6%)
Dec 2003
$22.67M(+42.7%)
$6.06M(+7.8%)
$22.67M(+3.6%)
Sep 2003
-
$5.62M(-6.2%)
$21.89M(+9.4%)
Jun 2003
-
$5.99M(+20.1%)
$20.02M(+12.6%)
Mar 2003
-
$4.99M(-5.5%)
$17.78M(+11.9%)
Dec 2002
$15.89M(-6.2%)
$5.28M(+40.9%)
$15.89M(+49.8%)
Sep 2002
-
$3.75M(-0.1%)
$10.61M(-5.3%)
Jun 2002
-
$3.75M(+21.1%)
$11.20M(-1.8%)
Mar 2002
-
$3.10M(>+9900.0%)
$11.41M(-12.7%)
Dec 2001
$16.94M(+44.4%)
$0.00(-100.0%)
$13.07M(0.0%)
Sep 2001
-
$4.34M(+9.4%)
$13.07M(+49.7%)
Jun 2001
-
$3.97M(-16.8%)
$8.73M(+83.2%)
Mar 2001
-
$4.76M(>+9900.0%)
$4.76M(>+9900.0%)
Dec 2000
$11.74M(+134.7%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$5.00M(+108.3%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00
$0.00
Dec 1998
$2.40M
-
-

FAQ

  • What is United Therapeutics Corporation annual SG&A?
  • What is the all-time high annual SG&A for United Therapeutics Corporation?
  • What is United Therapeutics Corporation annual SG&A year-on-year change?
  • What is United Therapeutics Corporation quarterly SG&A?
  • What is the all-time high quarterly SG&A for United Therapeutics Corporation?
  • What is United Therapeutics Corporation quarterly SG&A year-on-year change?
  • What is United Therapeutics Corporation TTM SG&A?
  • What is the all-time high TTM SG&A for United Therapeutics Corporation?
  • What is United Therapeutics Corporation TTM SG&A year-on-year change?

What is United Therapeutics Corporation annual SG&A?

The current annual SG&A of UTHR is $638.60M

What is the all-time high annual SG&A for United Therapeutics Corporation?

United Therapeutics Corporation all-time high annual SG&A is $638.60M

What is United Therapeutics Corporation annual SG&A year-on-year change?

Over the past year, UTHR annual SG&A has changed by +$161.50M (+33.85%)

What is United Therapeutics Corporation quarterly SG&A?

The current quarterly SG&A of UTHR is $152.00M

What is the all-time high quarterly SG&A for United Therapeutics Corporation?

United Therapeutics Corporation all-time high quarterly SG&A is $211.34M

What is United Therapeutics Corporation quarterly SG&A year-on-year change?

Over the past year, UTHR quarterly SG&A has changed by +$30.90M (+25.52%)

What is United Therapeutics Corporation TTM SG&A?

The current TTM SG&A of UTHR is $30.81B

What is the all-time high TTM SG&A for United Therapeutics Corporation?

United Therapeutics Corporation all-time high TTM SG&A is $30.81B

What is United Therapeutics Corporation TTM SG&A year-on-year change?

Over the past year, UTHR TTM SG&A has changed by +$30.31B (+5965.57%)
On this page